Jill Fehrenbacher

Title: Jill Fehrenbacher: Innovator in Neuroinflammation Research

Introduction

Jill Fehrenbacher is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of neuroinflammation, particularly in relation to diabetes and chronic pain. Her innovative work focuses on methods to reduce neuronal sensitivity and inflammation.

Latest Patents

Jill Fehrenbacher holds a patent titled "Prevention and reversal of inflammation induced DNA damage." This patent discloses methods for reducing neuronal sensitivity, thereby alleviating inflammation and chronic pain in subjects with diabetes. The patent particularly highlights the administration of the apurinic/apyrimidinic endonuclease 1 redox factor 1 (APE 1/Ref-1) inhibitor, APX3330, to enhance the DNA base excision repair (BER) pathway. This innovative approach aims to reduce neuronal sensitivity to inflammatory mediators and alleviate chronic pain.

Career Highlights

Fehrenbacher's career is marked by her dedication to research and innovation in the medical field. She is affiliated with Indiana University, where she continues to explore the complexities of neuroinflammation and its implications for chronic pain management. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from diabetes-related complications.

Collaborations

Jill Fehrenbacher collaborates with Mark R. Kelley, a fellow researcher, to advance their understanding of neuroinflammation and its treatment. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Jill Fehrenbacher is a trailblazer in the field of neuroinflammation research, with a focus on innovative methods to combat chronic pain in diabetic patients. Her contributions through patents and collaborations highlight her commitment to improving healthcare outcomes.